SF3B1 and glioblastoma: To the best of our knowledge, this is the first report identifying the diagnostic and prognostic capacity of SF3B1 in human GBM, and in glioma mouse models with different prognoses, wherein these observations suggest a causal link between SF3B1 dysregulation and GBM aggressiveness.